4.5 Article

Cell-death-inducing monoclonal antibodies raised against DT40 tumor cells: Identification of chicken transferrin receptor as a novel cell-death receptor

Journal

CANCER SCIENCE
Volume 99, Issue 5, Pages 894-900

Publisher

BLACKWELL PUBLISHING
DOI: 10.1111/j.1349-7006.2008.00753.x

Keywords

-

Categories

Ask authors/readers for more resources

We obtained unique cell-death-inducing monoclonal antibodies (mAbs) named D18 and D19 against chicken DT40 cells. D18 and D19 caused several signs of apoptosis, such as exposed phosphatidyl serine on the cell surface, a sub G(0)/G(1) peak, and DNA fragmentation, and inhibited the proliferation of DT40 cells. Flow cytometric and immunohistological analyses of various normal chicken tissues revealed the expression of the antigen recognized by these mAbs to be restricted to cells in lymphoid organs including bone marrow and bursa of fabricius, and to cells in some epithelial tissues. The cell death induced by the mAbs progressed through a mitochondrial pathway with loss of mitochondrial membrane potential. Apoptosis is generally characterized by cell shrinking; however, D18 and D19 elicited swelling, which preceded the cell death. We analyzed the antigen immunoprecipitated by the mAbs, and identified a 90- to 100-kDa cell-surface glycoprotein as the chicken transferrin receptor (TfR). Epitopes recognized by the two mAbs were confirmed to be different by the binding inhibition assay. The reactivity of the mAbs against DT40 cells was not inhibited by excess chicken serum, suggesting that the cell death induced by D18 and D19 was not caused by inhibition of the binding of transferrin (Tf) to chicken TfR. Since D18 and D19 have induced cell death in human embryonic kidney cells transfected with cDNA of the full-length chicken TfR, we expect human TfR to be a promising target in antibody therapy for various human malignancies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Nitrogen-containing bisphosphonate induces a newly discovered hematopoietic structure in the omentum of an anemic mouse model by stimulating G-CSF production

Hirotada Otsuka, Hideki Yagi, Yasuo Endo, Satoshi Soeta, Naoko Nonaka, Masanori Nakamura

CELL AND TISSUE RESEARCH (2017)

Article Immunology

Specific niches for lung-resident memory CD8+ T cells at the site of tissue regeneration enable CD69-independent maintenance

Shiki Takamura, Hideki Yagi, Yoshiyuki Hakata, Chihiro Motozono, Sean R. McMaster, Tomoko Masumoto, Makoto Fujisawa, Tomomi Chikaishi, Junko Komeda, Jun Itoh, Miki Umemura, Ami Kyusai, Michio Tomura, Toshinori Nakayama, David L. Woodland, Jacob E. Kohlmeier, Masaaki Miyazawa

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Article Chemistry, Organic

Stereochemical assignments of rubiaquinones A-C, naphthoquinone derivatives from &ITRubia yunnanensis&IT

Yoshihiro Suyama, Yusuke Higashino, Naonobu Tanaka, Yutaka Tatano, Hideki Yagi, Kazuyoshi Kawazoe, Kotaro Murakami, Shun-Lin Li, Han-Dong Sun, Yoshiki Kashiwada

TETRAHEDRON LETTERS (2017)

Article Oncology

YM155 exerts potent cytotoxic activity against quiescent (G0/G1) multiple myeloma and bortezomib resistant cells via inhibition of survivin and Mcl-1

Miyuki Ookura, Tatsuya Fujii, Hideki Yagi, Takuya Ogawa, Shinji Kishi, Naoko Hosono, Hiroko Shigemi, Takahiro Yamauchi, Takanori Ueda, Akira Yoshida

ONCOTARGET (2017)

Article Chemistry, Organic

Phloroglucinol derivatives and a chromone glucoside from the leaves of Myrtus communis

Naonobu Tanaka, Yuyu Jia, Kanji Niwa, Kiyoshi Imabayashi, Yutaka Tatano, Hideki Yagi, Yoshiki Kashiwada

TETRAHEDRON (2018)

Article Oncology

CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth

Takatsugu Ishimoto, Osamu Nagano, Toshifumi Yae, Mayumi Tamada, Takeshi Motohara, Hiroko Oshima, Masanobu Oshima, Tatsuya Ikeda, Rika Asaba, Hideki Yagi, Takashi Masuko, Takatsune Shimizu, Tomoki Ishikawa, Kazuharu Kai, Eri Takahashi, Yu Imamura, Yoshifumi Baba, Mitsuyo Ohmura, Makoto Suematsu, Hideo Baba, Hideyuki Saya

CANCER CELL (2011)

Article Oncology

NIH3T3 cells overexpressing CD98 heavy chain resist early G1 arrest and apoptosis induced by serum starvation

Kaori Hara, Shiho Ueda, Yoshiya Ohno, Toshiyuki Tanaka, Hideki Yagi, Shogo Okazaki, Rieko Kawahara, Takechi Masayuki, Takemi Enomoto, Yoshiyuki Hashimoto, Kazue Masuko, Takashi Masuko

CANCER SCIENCE (2012)

Article Oncology

Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1

Yuta Hara, Ryota Torii, Shiho Ueda, Erina Kurimoto, Eri Ueda, Hiroshi Okura, Yutaka Tatano, Hideki Yagi, Yoshiya Ohno, Toshiyuki Tanaka, Kazue Masuko, Takashi Masuko

CANCER SCIENCE (2018)

Article Cell Biology

Involvement of intestinal intraepithelial lymphocytes in turnover of intestinal epithelial cells; Morphological and functional alterations due to daily administration of FK506

Mayumi Hidaka, Masanori Nakamura, Yukari Ohmichi, Jun Itoh, Kenji Fukuzawa, Takashi Masuko, Hideki Yagi

CELLULAR IMMUNOLOGY (2012)

Article Immunology

S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1

Yasuhiro Maeda, Hideki Yagi, Kana Takemoto, Hiroyuki Utsumi, Atsushi Fukunari, Kunio Sugahara, Takashi Masuko, Kenji Chiba

INTERNATIONAL IMMUNOLOGY (2014)

Article Infectious Diseases

Management bundles for candidaemia: the impact of compliance on clinical outcomes

Yoshio Takesue, Takashi Ueda, Hiroshige Mikamo, Shigeto Oda, Shunji Takakura, Yuko Kitagawa, Shigeru Kohno

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)

Article Pharmacology & Pharmacy

Ouabain exerts cytoprotection by diminishing the intracellular K+ concentration increase caused by distinct stimuli in human leukemic cells

Masayuki Takechi, Tetsuyuki Wada, Hideki Yagi, Takashi Masuko, Atsufumi Kawabata

JOURNAL OF PHARMACY AND PHARMACOLOGY (2015)

Article Multidisciplinary Sciences

Anti-Tumor Effect against Human Cancer Xenografts by a Fully Human Monoclonal Antibody to a Variant 8-Epitope of CD44R1 Expressed on Cancer Stem Cells

Kazue Masuko, Shogo Okazaki, Mayumi Satoh, Goh Tanaka, Tatsuya Ikeda, Ryota Torii, Eri Ueda, Takashi Nakano, Masaaki Danbayashi, Tomoyo Tsuruoka, Yoshiya Ohno, Hideki Yagi, Noritsugu Yabe, Hideaki Yoshida, Tomoyuki Tahara, Shiro Kataoka, Taichi Oshino, Takayuki Shindo, Shin-ichiro Niwa, Takatsugu Ishimoto, Hideo Baba, Yoshiyuki Hashimoto, Hideyuki Saya, Takashi Masuko

PLOS ONE (2012)

Review Pharmacology & Pharmacy

An Efficient Method for Producing Monoclonal Antibodies against Multi-pass Membrane Proteins

Hideki Yagi, Takashi Masuko

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2013)

Review Pharmacology & Pharmacy

Team-based Learning (TBL) in the Interdisciplinary Lecture

Keiji Nishiwaki, Atsushi Kawase, Tetsuyuki Wada, Hideki Yagi, Naohito Kawasaki, Eiji Ito, Masahiro Iwaki

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2014)

No Data Available